{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T10:27:26Z","timestamp":1792578446832,"version":"4.5.0"},"reference-count":99,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,11,11]],"date-time":"2023-11-11T00:00:00Z","timestamp":1699660800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001807","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo","doi-asserted-by":"publisher","award":["2018\/13877\\u20131"],"award-info":[{"award-number":["2018\/13877\\u20131"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001807","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo","doi-asserted-by":"publisher","award":["2019\/08582\\u20135"],"award-info":[{"award-number":["2019\/08582\\u20135"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001807","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo","doi-asserted-by":"publisher","award":["2020\/01208\\u20138"],"award-info":[{"award-number":["2020\/01208\\u20138"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002322","name":"CAPES","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["306866\/2020\\u20130"],"award-info":[{"award-number":["306866\/2020\\u20130"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1016\/j.ejps.2023.106638","type":"journal-article","created":{"date-parts":[[2023,11,13]],"date-time":"2023-11-13T02:10:52Z","timestamp":1699841452000},"page":"106638","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"special_numbering":"C","title":["Nanostructured lipid carriers loaded into in situ gels for breast cancer local treatment"],"prefix":"10.1016","volume":"192","author":[{"given":"Julia S.","family":"Passos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexsandra C.","family":"Apolinario","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelly","family":"Ishida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tereza S.","family":"Martins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7814-9647","authenticated-orcid":false,"given":"Luciana B.","family":"Lopes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.ejps.2023.106638_bib0001","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1517\/17425247.2014.935335","article-title":"Compritol 888 ATO: a multifunctional lipid excipient in drug delivery systems and nanopharmaceuticals","volume":"11","author":"Aburahma","year":"2014","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.ejps.2023.106638_bib0002","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.jpba.2018.03.021","article-title":"Development of a HILIC method for the determination of 5-fluorouracil from nano drug delivery systems and rat skin extracts","volume":"154","author":"Amasya","year":"2018","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.ejps.2023.106638_bib0003","doi-asserted-by":"crossref","first-page":"45","DOI":"10.4103\/2277-9175.100147","article-title":"Optimization of LDL targeted nanostructured lipid carriers of 5-FU by a full factorial design","volume":"1","author":"Andalib","year":"2012","journal-title":"Adv. Biomed. Res."},{"issue":"4","key":"10.1016\/j.ejps.2023.106638_bib0004","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1208\/s12249-022-02257-1","article-title":"Rethinking breast cancer chemoprevention: technological advantages and enhanced performance of a nanoethosomal-based hydrogel for topical administration of fenretinide","volume":"23","author":"Apolin\u00e1rio","year":"2022","journal-title":"AAPS PharmSciTech."},{"issue":"6","key":"10.1016\/j.ejps.2023.106638_bib0005","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.pathol.2019.07.005","article-title":"Ductal carcinoma in situ of breast: update 2019","volume":"51","author":"Badve","year":"2019","journal-title":"Pathology"},{"issue":"6","key":"10.1016\/j.ejps.2023.106638_bib0006","doi-asserted-by":"crossref","DOI":"10.3390\/cancers11060807","article-title":"The delivery strategy of paclitaxel nanostructured lipid carrier coated with platelet membrane","volume":"11","author":"Bang","year":"2019","journal-title":"Cancers"},{"key":"10.1016\/j.ejps.2023.106638_bib0007","series-title":"An Introduction to Rheology","first-page":"199","author":"Barnes","year":"1989"},{"issue":"1\u20132","key":"10.1016\/j.ejps.2023.106638_bib0008","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/j.ijpharm.2017.05.016","article-title":"Paclitaxel: what has been done and the challenges remain ahead","volume":"526","author":"Bernabeu","year":"2017","journal-title":"Int. J. Pharm."},{"issue":"4","key":"10.1016\/j.ejps.2023.106638_bib0009","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1053\/gast.2001.22440","article-title":"Synergistic efficacy of 3n-butyrate and 5-fluorouracil in human colorectal cancer xenografts via modulation of DNA synthesis","volume":"120","author":"Bras-Gon\u00e7alves","year":"2001","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ejps.2023.106638_bib0010","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.ejps.2017.07.023","article-title":"Co-encapsulation of paclitaxel and C6 ceramide in tributyrin-containing nanocarriers improve co-localization in the skin and potentiate cytotoxic effects in 2D and 3D models","volume":"109","author":"Carvalho","year":"2017","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2023.106638_bib0011","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2019.118460","article-title":"Optimization of composition and obtainment parameters of biocompatible nanoemulsions intended for intraductal administration of piplartine (piperlongumine) and mammary tissue targeting","volume":"567","author":"Carvalho","year":"2019","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2023.106638_bib0012","doi-asserted-by":"crossref","DOI":"10.1016\/j.colsurfb.2020.111535","article-title":"Design and evaluation of cabazitaxel loaded NLCs against breast cancer cell lines","volume":"199","author":"Chand","year":"2021","journal-title":"Colloids Surf. B Biointerfaces"},{"issue":"11","key":"10.1016\/j.ejps.2023.106638_bib0013","doi-asserted-by":"crossref","first-page":"2242","DOI":"10.1093\/carcin\/bgs248","article-title":"Intraductal administration of a polymeric nanoparticle formulation of curcumin (NanoCurc) significantly attenuates incidence of mammary tumors in a rodent chemical carcinogenesis model: implications for breast cancer chemoprevention in at-risk populations","volume":"33","author":"Chun","year":"2012","journal-title":"Carcinogenesis"},{"issue":"5","key":"10.1016\/j.ejps.2023.106638_bib0014","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.apsb.2017.03.002","article-title":"Amino-functionalized poloxamer 407 with both mucoadhesive and thermosensitive properties: preparation, characterization and application in a vaginal drug delivery system","volume":"7","author":"Ci","year":"2017","journal-title":"Acta Pharm. Sin. B"},{"issue":"12","key":"10.1016\/j.ejps.2023.106638_bib0015","doi-asserted-by":"crossref","DOI":"10.3390\/ma14123197","article-title":"Non-ionic surfactants for stabilization of polymeric nanoparticles for biomedical uses","volume":"14","author":"Cort\u00e9s","year":"2021","journal-title":"Materials"},{"issue":"2","key":"10.1016\/j.ejps.2023.106638_bib0016","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0928-0987(01)00095-1","article-title":"Modeling and comparison of dissolution profiles","volume":"13","author":"Costa","year":"2001","journal-title":"Eur. J. Pharm. Sci."},{"issue":"2","key":"10.1016\/j.ejps.2023.106638_bib0017","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics10020057","article-title":"Impact of particle size and polydispersity index on the clinical applications of lipidic nanocarrier systems","volume":"10","author":"Danaei","year":"2018","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ejps.2023.106638_bib0018","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2022.07.162","article-title":"Hyaluronic acid nanoemulsions improve piplartine cytotoxicity in 2D and 3D breast cancer models and reduce tumor development after intraductal administration","author":"Dartora","year":"2022","journal-title":"Int. J. Biol. Macromol."},{"issue":"12","key":"10.1016\/j.ejps.2023.106638_bib0019","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1016\/S1470-2045(22)00632-5","article-title":"Fluorouracil and dose-dense adjuvant chemotherapy in patients with early-stage breast cancer (GIM2): end-of-study results from a randomised, phase 3 trial","volume":"23","author":"Del Mastro","year":"2022","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.ejps.2023.106638_bib0020","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1016\/j.ijbiomac.2014.09.021","article-title":"Effect of methyl cellulose on gelation behavior and drug release from poloxamer based ophthalmic formulations","volume":"72","author":"Dewan","year":"2015","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.ejps.2023.106638_bib0021","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1007\/BF02540548","article-title":"Density and viscosity of low-molecular weight triglycerides and their mixtures","volume":"71","author":"Eiteman","year":"1994","journal-title":"J. Am. Oil Chem. Soc."},{"issue":"9","key":"10.1016\/j.ejps.2023.106638_bib0022","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1001\/jamaoncol.2015.3062","article-title":"Effectiveness of an adjuvant chemotherapy regimen for early-stage breast cancer: a systematic review and network meta-analysis","volume":"1","author":"Fujii","year":"2015","journal-title":"JAMA Oncol."},{"key":"10.1016\/j.ejps.2023.106638_bib0023","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2023.106465","article-title":"Development and cytotoxicity evaluation of multiple nanoemulsions for oral co-delivery of 5-fluorouracil and short chain triglycerides for colorectal cancer","volume":"187","author":"Fukumori","year":"2023","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2023.106638_bib0024","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2021.120877","article-title":"Development and preclinical evaluation of microneedle-assisted resveratrol loaded nanostructured lipid carriers for localized delivery to breast cancer therapy","volume":"606","author":"Gadag","year":"2021","journal-title":"Int. J. Pharm."},{"issue":"7","key":"10.1016\/j.ejps.2023.106638_bib0025","doi-asserted-by":"crossref","first-page":"576","DOI":"10.21037\/atm-21-1540","article-title":"Intraductal administration of N-methyl-N-nitrosourea as a novel rodent mammary tumor model","volume":"9","author":"Gao","year":"2021","journal-title":"Ann. Transl. Med."},{"key":"10.1016\/j.ejps.2023.106638_bib0026","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.713616","article-title":"Nanostructured lipid carrier-mediated transdermal delivery of aceclofenac hydrogel present an effective therapeutic approach for inflammatory diseases","volume":"12","author":"Garg","year":"2021","journal-title":"Front. Pharmacol."},{"issue":"15","key":"10.1016\/j.ejps.2023.106638_bib0027","doi-asserted-by":"crossref","first-page":"12787","DOI":"10.1039\/C8NJ01986J","article-title":"Cytotoxicity studies of selected cadmium-based quantum dots on 2D vs. 3D cell cultures","volume":"42","author":"Grabowska-Jadach","year":"2018","journal-title":"New J. Chem."},{"issue":"8","key":"10.1016\/j.ejps.2023.106638_bib0028","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1517\/14656566.7.8.1041","article-title":"Albumin-bound paclitaxel: a next-generation taxane","volume":"7","author":"Gradishar","year":"2006","journal-title":"Expert Opin. Pharmacother."},{"key":"10.1016\/j.ejps.2023.106638_bib0029","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.113525","article-title":"Folate receptor-mediated delivery of mitoxantrone-loaded solid lipid nanoparticles to breast cancer cells","volume":"154","author":"Granja","year":"2022","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.ejps.2023.106638_bib0030","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.breast.2016.09.001","article-title":"Finding the balance between over- and under-treatment of ductal carcinoma in situ (DCIS)","volume":"31","author":"Groen","year":"2017","journal-title":"Breast"},{"key":"10.1016\/j.ejps.2023.106638_bib0031","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.ejps.2018.04.033","article-title":"The effect of size and polymer architecture of doxorubicin-poly(ethylene) glycol conjugate nanocarriers on breast duct retention, potency and toxicity","volume":"121","author":"Gu","year":"2018","journal-title":"Eur. J. Pharm. Sci."},{"issue":"9","key":"10.1016\/j.ejps.2023.106638_bib0032","doi-asserted-by":"crossref","first-page":"2912","DOI":"10.1007\/s11095-015-1673-7","article-title":"Modulation of pharmacokinetic and cytotoxicity profile of Imatinib base by employing optimized nanostructured lipid carriers","volume":"32","author":"Gupta","year":"2015","journal-title":"Pharm. Res."},{"issue":"1","key":"10.1016\/j.ejps.2023.106638_bib0033","first-page":"3","article-title":"Development and validation of a new HPLC method for the detection of 5- fluorouracil in mobile phase and in plasma","volume":"14","author":"Hanif","year":"2018","journal-title":"Curr. Pharm. Anal."},{"issue":"7","key":"10.1016\/j.ejps.2023.106638_bib0034","first-page":"1584","article-title":"Initiation of growth arrest and apoptosis of MCF-7 mammary carcinoma cells by tributyrin, a triglyceride analogue of the short-chain fatty acid butyrate, is associated with mitochondrial activity","volume":"59","author":"Heerdt","year":"1999","journal-title":"Cancer Res."},{"issue":"14","key":"10.1016\/j.ejps.2023.106638_bib0035","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.2174\/138945012804545443","article-title":"Anticarcinogenic actions of tributyrin, a butyric acid prodrug","volume":"13","author":"Heidor","year":"2012","journal-title":"Curr. Drug Targets"},{"issue":"4","key":"10.1016\/j.ejps.2023.106638_bib0036","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1186\/bcr2889","article-title":"Choosing the right cell line for breast cancer research","volume":"13","author":"Holliday","year":"2011","journal-title":"Breast Cancer Res."},{"issue":"4","key":"10.1016\/j.ejps.2023.106638_bib0037","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1002\/jps.22370","article-title":"Influence of internal structure and composition of liquid crystalline phases on topical delivery of paclitaxel","volume":"100","author":"Hosmer","year":"2011","journal-title":"J. Pharm. Sci."},{"issue":"3","key":"10.1016\/j.ejps.2023.106638_bib0038","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1007\/s11095-012-0908-0","article-title":"Lamellar liquid crystalline phases for cutaneous delivery of Paclitaxel: impact of the monoglyceride","volume":"30","author":"Hosmer","year":"2013","journal-title":"Pharm. Res."},{"issue":"2","key":"10.1016\/j.ejps.2023.106638_bib0039","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1080\/13685538.2017.1350156","article-title":"Reference database of hematological parameters for growing and aging rats","volume":"21","author":"Jacob Filho","year":"2018","journal-title":"Aging Male"},{"key":"10.1016\/j.ejps.2023.106638_bib0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.chemphyslip.2016.10.005","article-title":"In vitro release kinetics model fitting of liposomes: an insight","author":"Jain","year":"2016","journal-title":"Chem. Phys. Lipids"},{"issue":"28","key":"10.1016\/j.ejps.2023.106638_bib0041","doi-asserted-by":"crossref","first-page":"6758","DOI":"10.1016\/j.biomaterials.2012.05.026","article-title":"Polyelectrolyte stabilized multilayered liposomes for oral delivery of paclitaxel","volume":"33","author":"Jain","year":"2012","journal-title":"Biomaterials"},{"issue":"2","key":"10.1016\/j.ejps.2023.106638_bib0042","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S0378-5173(00)00378-1","article-title":"Characterisation of a novel solid lipid nanoparticle carrier system based on binary mixtures of liquid and solid lipids","volume":"199","author":"Jenning","year":"2000","journal-title":"Int. J. Pharm."},{"issue":"2","key":"10.1016\/j.ejps.2023.106638_bib0043","first-page":"441","article-title":"Intraductal drug delivery to the breast: effect of particle size and formulation on breast duct and lymph node retention","volume":"17","author":"Joseph","year":"2020","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ejps.2023.106638_bib0044","doi-asserted-by":"crossref","DOI":"10.1016\/j.tiv.2022.105461","article-title":"Monolayer (2D) or spheroids (3D) cell cultures for nanotoxicological studies? Comparison of cytotoxicity and cell internalization of nanoparticles","volume":"85","author":"Juarez-Moreno","year":"2022","journal-title":"Toxicol. in Vitro"},{"issue":"4","key":"10.1016\/j.ejps.2023.106638_bib0045","first-page":"910","article-title":"2D and 3D cell cultures - a comparison of different types of cancer cell cultures","volume":"14","author":"Kapa\u0142czy\u0144ska","year":"2018","journal-title":"Arch. Med. Sci."},{"key":"10.1016\/j.ejps.2023.106638_bib0046","doi-asserted-by":"crossref","first-page":"219","DOI":"10.33320\/maced.pharm.bull.2020.66.03.109","article-title":"Freeze-drying of nanostructured lipid carriers loaded with\u00a0 Salvia off. extract for Alzheimer's disease treatment","volume":"66","author":"Karakash","year":"2020","journal-title":"Maced. Pharm. Bull."},{"issue":"2","key":"10.1016\/j.ejps.2023.106638_bib0047","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics11020097","article-title":"Freeze-dried lopinavir-loaded nanostructured lipid carriers for enhanced cellular uptake and bioavailability: statistical optimization, in vitro and in vivo evaluations","volume":"11","author":"Khan","year":"2019","journal-title":"Pharmaceutics"},{"issue":"13","key":"10.1016\/j.ejps.2023.106638_bib0048","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1200\/JCO.20.03399","article-title":"Neoadjuvant chemotherapy, endocrine therapy, and targeted therapy for breast cancer: ASCO guideline","volume":"39","author":"Korde","year":"2021","journal-title":"J. Clin. Oncol."},{"issue":"2","key":"10.1016\/j.ejps.2023.106638_bib0049","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/s10911-020-09453-4","article-title":"Intraductal therapy in breast cancer: current status and future prospective","volume":"25","author":"Kuang","year":"2020","journal-title":"J. Mammary Gland Biol. Neoplasia"},{"key":"10.1016\/j.ejps.2023.106638_bib0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2020.111114","article-title":"Lipid-based nanocarriers co-loaded with artemether and triglycerides of docosahexaenoic acid: effects on human breast cancer cells","volume":"134","author":"Lanna","year":"2021","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.ejps.2023.106638_bib0051","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.foodchem.2015.12.037","article-title":"Size-controlled starch nanoparticles prepared by self-assembly with different green surfactant: the effect of electrostatic repulsion or steric hindrance","volume":"199","author":"Li","year":"2016","journal-title":"Food Chem."},{"issue":"5","key":"10.1016\/j.ejps.2023.106638_bib0052","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/nrc1074","article-title":"5-fluorouracil: mechanisms of action and clinical strategies","volume":"3","author":"Longley","year":"2003","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.ejps.2023.106638_bib0053","article-title":"Biocomposites based on SBA-15 and papain: characterization, enzymatic activity and cytotoxicity evaluation","volume":"325","author":"Losito","year":"2021"},{"issue":"1","key":"10.1016\/j.ejps.2023.106638_bib0054","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1158\/1940-6207.CAPR-12-0228","article-title":"A feasibility study of the intraductal administration of chemotherapy","volume":"6","author":"Love","year":"2013","journal-title":"Cancer Prev. Res."},{"issue":"4","key":"10.1016\/j.ejps.2023.106638_bib0055","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.clbc.2013.02.002","article-title":"Intraductal therapy of ductal carcinoma in situ: a presurgery study","volume":"13","author":"Mahoney","year":"2013","journal-title":"Clin. Breast Cancer"},{"issue":"5","key":"10.1016\/j.ejps.2023.106638_bib0056","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics14051034","article-title":"Development of \u03b1-tocopherol succinate-based nanostructured lipid carriers for delivery of paclitaxel","volume":"14","author":"Marathe","year":"2022","journal-title":"Pharmaceutics"},{"issue":"340","key":"10.1016\/j.ejps.2023.106638_bib0057","article-title":"Lipid-based nanoparticles as drug delivery system for paclitaxel in breast cancer treatment","volume":"19","author":"Marcial","year":"2017","journal-title":"J. Nanopart. Res."},{"issue":"5","key":"10.1016\/j.ejps.2023.106638_bib0058","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1517\/14740338.6.5.609","article-title":"Paclitaxel: a review of adverse toxicities and novel delivery strategies","volume":"6","author":"Marupudi","year":"2007","journal-title":"Expert Opin. Drug Saf."},{"issue":"2","key":"10.1016\/j.ejps.2023.106638_bib0059","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1023\/A:1026491221687","article-title":"A developmental atlas of rat mammary gland histology","volume":"5","author":"Masso-Welch","year":"2000","journal-title":"J. Mammary Gland Biol. Neoplasia"},{"issue":"1","key":"10.1016\/j.ejps.2023.106638_bib0060","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1208\/s12249-020-01874-y","article-title":"Impact of membranes on in vitro release assessment: a case study using dexamethasone","volume":"22","author":"Mekjaruskul","year":"2021","journal-title":"AAPS PharmSciTech."},{"issue":"1","key":"10.1016\/j.ejps.2023.106638_bib0061","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1080\/10717544.2018.1440665","article-title":"Multifunctional nanoemulsions for intraductal delivery as a new platform for local treatment of breast cancer","volume":"25","author":"Migotto","year":"2018","journal-title":"Drug Deliv."},{"issue":"3","key":"10.1016\/j.ejps.2023.106638_bib0062","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.cpet.2018.02.006","article-title":"Overview of breast cancer therapy","volume":"13","author":"Moo","year":"2018","journal-title":"PET Clin."},{"issue":"2","key":"10.1016\/j.ejps.2023.106638_bib0063","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1158\/0008-5472.CAN-05-4329","article-title":"Ductal access for prevention and therapy of mammary tumors","volume":"66","author":"Murata","year":"2006","journal-title":"Cancer Res."},{"issue":"7","key":"10.1016\/j.ejps.2023.106638_bib0064","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1001\/jamaoncol.2015.2510","article-title":"Breast cancer mortality after a diagnosis of ductal carcinoma in situ","volume":"1","author":"Narod","year":"2015","journal-title":"JAMA Oncol."},{"key":"10.1016\/j.ejps.2023.106638_bib0067","unstructured":"National Center for Biotechnology Information (2023). PubChem Compound Summary for CID 6050, Tributyrin. Retrieved November 20, 2023 from https:\/\/pubchem.ncbi.nlm.nih.gov\/compound\/Tributyrin.CopyAMA."},{"key":"10.1016\/j.ejps.2023.106638_bib0065","unstructured":"National Center for Biotechnology Information (2023). PubChem Compound Summary for CID 3385, Fluorouracil. Retrieved November 20, 2023 from https:\/\/pubchem.ncbi.nlm.nih.gov\/compound\/Fluorouracil."},{"key":"10.1016\/j.ejps.2023.106638_bib0066","unstructured":"National Center for Biotechnology Information (2023). PubChem Compound Summary for CID 36314, Paclitaxel. Retrieved November 20, 2023 from https:\/\/pubchem.ncbi.nlm.nih.gov\/compound\/Paclitaxel."},{"issue":"1","key":"10.1016\/j.ejps.2023.106638_bib0068","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/s10549-004-6455-6","article-title":"Effect of perductal paclitaxel exposure on the development of MNU-induced mammary carcinoma in female S-D rats","volume":"91","author":"Okugawa","year":"2005","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.ejps.2023.106638_bib0069","doi-asserted-by":"crossref","DOI":"10.1016\/j.msec.2020.111255","article-title":"A multifunctional nanomedicine platform for co-delivery of methotrexate and mild hyperthermia towards breast cancer therapy","volume":"116","author":"Ong","year":"2020","journal-title":"Mater. Sci. Eng. C"},{"key":"10.1016\/j.ejps.2023.106638_bib0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2020.105296","article-title":"Development, skin targeting and antifungal efficacy of topical lipid nanoparticles containing itraconazole","volume":"149","author":"Passos","year":"2020","journal-title":"Eur. J. Pharm. Sci."},{"issue":"6","key":"10.1016\/j.ejps.2023.106638_bib0071","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1208\/s12249-014-0168-x","article-title":"Characterization and evaluation of 5-fluorouracil-loaded solid lipid nanoparticles prepared via a temperature-modulated solidification technique","volume":"15","author":"Patel","year":"2014","journal-title":"AAPS PharmSciTech."},{"key":"10.1016\/j.ejps.2023.106638_bib0072","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2020.119563","article-title":"Strategic consideration for effective chemotherapeutic transportation via transpapillary route in breast cancer","volume":"586","author":"Patil","year":"2020","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2023.106638_bib0073","article-title":"Optimization and in vitro\/in vivo performance of paclitaxel-loaded nanostructured lipid carriers for breast cancer treatment","volume":"54","author":"Pedro","year":"2019","journal-title":"J. Drug Deliv. Sci. Technol."},{"issue":"12","key":"10.1016\/j.ejps.2023.106638_bib0074","doi-asserted-by":"crossref","DOI":"10.3390\/antibiotics10121545","article-title":"The versatile host for drug discovery, in vivo toxicity testing and characterising host-pathogen interactions","volume":"10","author":"Piatek","year":"2021","journal-title":"Antibiotics"},{"key":"10.1016\/j.ejps.2023.106638_bib0075","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1016\/j.colsurfb.2019.06.004","article-title":"Resveratrol loaded functionalized nanostructured lipid carriers for breast cancer targeting: systematic development, characterization and pharmacokinetic evaluation","volume":"181","author":"Poonia","year":"2019","journal-title":"Colloids Surf. B Biointerfaces"},{"key":"10.1016\/j.ejps.2023.106638_bib0076","doi-asserted-by":"crossref","first-page":"5067","DOI":"10.2147\/IJN.S117511","article-title":"Development and evaluation of nanostructured lipid carrier-based hydrogel for topical delivery of 5-fluorouracil","volume":"11","author":"Rajinikanth","year":"2016","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.ejps.2023.106638_bib0077","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.jcis.2012.08.069","article-title":"Fabrication of vitamin E-enriched nanoemulsions: factors affecting particle size using spontaneous emulsification","volume":"391","author":"Saberi","year":"2013","journal-title":"J. Colloid Interface Sci."},{"key":"10.1016\/j.ejps.2023.106638_bib0078","doi-asserted-by":"crossref","first-page":"192","DOI":"10.3389\/fonc.2017.00192","article-title":"Paradigm shift toward reducing overtreatment of ductal carcinoma","volume":"7","author":"Sagara","year":"2017","journal-title":"Front. Oncol."},{"issue":"9","key":"10.1016\/j.ejps.2023.106638_bib0079","doi-asserted-by":"crossref","DOI":"10.3390\/ph15091110","article-title":"Phosphatidylcholine-based nanoemulsions for paclitaxel and a p-glycoprotein inhibitor delivery and breast cancer intraductal treatment","volume":"15","author":"Salata","year":"2022","journal-title":"Pharmaceuticals"},{"issue":"9","key":"10.1016\/j.ejps.2023.106638_bib0080","doi-asserted-by":"crossref","first-page":"3401","DOI":"10.1021\/acs.molpharmaceut.1c00319","article-title":"Microemulsion for prolonged release of fenretinide in the mammary tissue and prevention of breast cancer development","volume":"18","author":"Salata","year":"2021","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ejps.2023.106638_bib0081","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2023.122681","article-title":"Contributions of nanotechnology to the intraductal drug delivery for local treatment and prevention of breast cancer","volume":"635","author":"Sapienza Passos","year":"2023","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2023.106638_bib0082","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.jddst.2016.05.007","article-title":"In situ thermosensitive Tamoxifen citrate loaded hydrogels: an effective tool in breast cancer loco-regional therapy","volume":"35","author":"Shaker","year":"2016","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"10.1016\/j.ejps.2023.106638_bib0083","doi-asserted-by":"crossref","first-page":"5449","DOI":"10.2147\/IJN.S73010","article-title":"Follicular delivery of spironolactone via nanostructured lipid carriers for management of alopecia","volume":"9","author":"Shamma","year":"2014","journal-title":"Int. J. Nanomed."},{"issue":"9","key":"10.1016\/j.ejps.2023.106638_bib0084","doi-asserted-by":"crossref","first-page":"2377","DOI":"10.1007\/s11095-012-0763-z","article-title":"Influence of molecular size on the retention of polymeric nanocarrier diagnostic agents in breast ducts","volume":"29","author":"Singh","year":"2012","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejps.2023.106638_bib0085","series-title":"Physical Pharmacy And Pharmaceutical Sciences: Physical Chemical and Biopharmaceutical Principles in the Pharmaceutical Sciences","first-page":"469","article-title":"Rheology","author":"Sinko","year":"2011"},{"issue":"8","key":"10.1016\/j.ejps.2023.106638_bib0086","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1016\/j.drudis.2019.05.036","article-title":"Poloxamer-based in situ gelling thermoresponsive systems for ocular drug delivery applications","volume":"24","author":"Soliman","year":"2019","journal-title":"Drug Discov. Today"},{"issue":"106","key":"10.1016\/j.ejps.2023.106638_bib0087","doi-asserted-by":"crossref","first-page":"106ra108","DOI":"10.1126\/scitranslmed.3002368","article-title":"Preclinical and clinical evaluation of intraductally administered agents in early breast cancer","volume":"3","author":"Stearns","year":"2011","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.ejps.2023.106638_bib0088","article-title":"Magnetic-guided targeted delivery of zerumbone\/SPION co-loaded in nanostructured lipid carrier into breast cancer cells","volume":"87","author":"Tan","year":"2023","journal-title":"J. Drug Deliv. Sci. Technol."},{"issue":"7","key":"10.1016\/j.ejps.2023.106638_bib0089","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1080\/10837450.2019.1616755","article-title":"Thermosensitive hydrogel containing sertaconazole loaded nanostructured lipid carriers for potential treatment of fungal keratitis","volume":"24","author":"Tavakoli","year":"2019","journal-title":"Pharm. Dev. Technol."},{"issue":"2","key":"10.1016\/j.ejps.2023.106638_bib0090","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.ejps.2013.03.013","article-title":"Development of solid lipid nanoparticles based controlled release system for topical delivery of terbinafine hydrochloride","volume":"49","author":"Vaghasiya","year":"2013","journal-title":"Eur. J. Pharm. Sci."},{"issue":"4","key":"10.1016\/j.ejps.2023.106638_bib0091","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1038\/s41416-019-0478-6","article-title":"Ductal carcinoma in situ: to treat or not to treat, that is the question","volume":"121","author":"van Seijen","year":"2019","journal-title":"Br. J. Cancer"},{"issue":"4","key":"10.1016\/j.ejps.2023.106638_bib0092","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics13040436","article-title":"Changes in skin barrier function after repeated exposition to phospholipid-based surfactants and sodium dodecyl sulfate in vivo and corneocyte surface analysis by atomic force microscopy","volume":"13","author":"Vater","year":"2021","journal-title":"Pharmaceutics"},{"issue":"10","key":"10.1016\/j.ejps.2023.106638_bib0093","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1016\/j.ejca.2005.02.028","article-title":"Choline and phosphatidylcholine fluorescent derivatives localization in carcinoma cells studied by laser scanning confocal fluorescence microscopy","volume":"41","author":"Villa","year":"2005","journal-title":"Eur. J. Cancer"},{"issue":"18","key":"10.1016\/j.ejps.2023.106638_bib0094","doi-asserted-by":"crossref","first-page":"2677","DOI":"10.1091\/mbc.e14-04-0916","article-title":"How Taxol\/paclitaxel kills cancer cells","volume":"25","author":"Weaver","year":"2014","journal-title":"Mol. Biol. Cell"},{"key":"10.1016\/j.ejps.2023.106638_bib0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2020.120146","article-title":"Lecithin coating as universal stabilization and functionalization strategy for nanosized drug carriers to overcome the blood-brain barrier","volume":"593","author":"W\u00fcnsch","year":"2021","journal-title":"Int. J. Pharm."},{"issue":"10","key":"10.1016\/j.ejps.2023.106638_bib0096","doi-asserted-by":"crossref","first-page":"3748","DOI":"10.1002\/jps.23686","article-title":"Development and evaluation of paclitaxel nanoparticles using a quality-by-design approach","volume":"102","author":"Yerlikaya","year":"2013","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2023.106638_bib0097","doi-asserted-by":"crossref","first-page":"6249","DOI":"10.2147\/IJN.S216432","article-title":"Intravesical delivery of rapamycin via folate-modified liposomes dispersed in thermo-reversible hydrogel","volume":"14","author":"Yoon","year":"2019","journal-title":"Int J Nanomedicine"},{"issue":"8","key":"10.1016\/j.ejps.2023.106638_bib0098","doi-asserted-by":"crossref","DOI":"10.1002\/mabi.202100042","article-title":"Phosphatidylcholine-engineered exosomes for enhanced tumor cell uptake and intracellular antitumor drug delivery","volume":"21","author":"Zhan","year":"2021","journal-title":"Macromol. Biosci."},{"key":"10.1016\/j.ejps.2023.106638_bib0099","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.ejpb.2016.10.021","article-title":"Effect of drug solubility and lipid carrier on drug release from lipid nanoparticles for dermal delivery","volume":"110","author":"Zoubari","year":"2017","journal-title":"Eur. J. Pharm. Biopharm."}],"container-title":["European Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098723002683?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098723002683?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T16:16:56Z","timestamp":1778775416000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0928098723002683"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":99,"alternative-id":["S0928098723002683"],"URL":"https:\/\/doi.org\/10.1016\/j.ejps.2023.106638","relation":{},"ISSN":["0928-0987"],"issn-type":[{"value":"0928-0987","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Nanostructured lipid carriers loaded into in situ gels for breast cancer local treatment","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejps.2023.106638","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"106638"}}